Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion

INTRODUCTION: Liver cirrhosis can have a major impact on drug pharmacokinetics and pharmacodynamics. Patients with cirrhosis often suffer from potentially preventable adverse drug reactions. Guidelines on safe prescribing for these patients are lacking. The aim of this study is to develop a systemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Weersink, Rianne A, Bouma, Margriet, Burger, David M, Drenth, Joost P H, Hunfeld, Nicole G M, Kranenborg, Minke, Monster-Simons, Margje H, van Putten, Sandra A W, Metselaar, Herold J, Taxis, Katja, Borgsteede, Sander D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073492/
https://www.ncbi.nlm.nih.gov/pubmed/27733414
http://dx.doi.org/10.1136/bmjopen-2016-012991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073492/
https://www.ncbi.nlm.nih.gov/pubmed/27733414
http://dx.doi.org/10.1136/bmjopen-2016-012991

Ejemplares similares